HomeCompareLLY vs ALLE

LLY vs ALLE: Dividend Comparison 2026

LLY yields 0.70% · ALLE yields 1.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LLY wins by $1.39M in total portfolio value· pulled ahead in Year 5
10 years
LLY
LLY
● Live price
0.70%
Share price
$886.67
Annual div
$6.23
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.54M
Annual income
$1,207,534.19
Full LLY calculator →
ALLE
ALLE
● Live price
1.46%
Share price
$142.89
Annual div
$2.08
5Y div CAGR
60.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$150.1K
Annual income
$68,750.97
Full ALLE calculator →

Portfolio growth — LLY vs ALLE

📍 LLY pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLLYALLE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LLY + ALLE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LLY pays
ALLE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LLY
Annual income on $10K today (after 15% tax)
$59.72/yr
After 10yr DRIP, annual income (after tax)
$1,026,404.06/yr
ALLE
Annual income on $10K today (after 15% tax)
$123.73/yr
After 10yr DRIP, annual income (after tax)
$58,438.32/yr
At 15% tax rate, LLY beats the other by $967,965.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LLY + ALLE for your $10,000?

LLY: 50%ALLE: 50%
100% ALLE50/50100% LLY
Portfolio after 10yr
$843.9K
Annual income
$638,142.58/yr
Blended yield
75.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on LLY right now

LLY
Analyst Ratings
33
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$1,243.95
+40.3% upside vs current
Range: $985.00 — $1,350.00
Altman Z
7.7
Piotroski
6/9
ALLE
Analyst Ratings
8
Buy
15
Hold
Consensus: Hold
Price Target
$185.00
+29.5% upside vs current
Range: $180.00 — $190.00
Altman Z
4.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LLY buys
0
ALLE buys
0
No recent congressional trades found for LLY or ALLE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLLYALLE
Forward yield0.70%1.46%
Annual dividend / share$6.23$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%60.6%
Portfolio after 10y$1.54M$150.1K
Annual income after 10y$1,207,534.19$68,750.97
Total dividends collected$1.49M$122.2K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$1,243.95$185.00

Year-by-year: LLY vs ALLE ($10,000, DRIP)

YearLLY PortfolioLLY Income/yrALLE PortfolioALLE Income/yrGap
1$10,841$140.53$10,934$233.78$93.00ALLE
2$11,884$284.74$12,083$383.65$199.00ALLE
3$13,299$583.47$13,565$636.35$266.00ALLE
4$15,451$1,220.47$15,587$1,072.29$136.00ALLE
5← crossover$19,183$2,650.30$18,527$1,849.31+$656.00LLY
6$26,676$6,150.32$23,123$3,299.32+$3.6KLLY
7$44,530$15,986.45$30,923$6,180.58+$13.6KLLY
8$97,527$49,880.25$45,493$12,405.53+$52.0KLLY
9$308,551$204,197.51$76,070$27,393.22+$232.5KLLY
10$1,537,684$1,207,534.19$150,146$68,750.97+$1.39MLLY

LLY vs ALLE: Complete Analysis 2026

LLYHealthcare

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Full LLY Calculator →

ALLEStock

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facilities, including education, healthcare, government, hospitality, commercial office, and single and multi-family residential markets under the CISA, Interflex, LCN, Schlage, SimonsVoss, and Von Duprin brands. It sells its products and solutions through distribution and retail channels, such as specialty distribution, e-commerce, and wholesalers, as well as through various retail channels comprising do-it-yourself home improvement centers, on-line and e-commerce platforms, and small specialty showroom outlets. Allegion plc was incorporated in 2013 and is headquartered in Dublin, Ireland.

Full ALLE Calculator →
📬

Get this LLY vs ALLE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LLY vs SCHDLLY vs JEPILLY vs OLLY vs KOLLY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.